SACCARDI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.491
EU - Europa 1.639
AS - Asia 812
SA - Sud America 78
AF - Africa 19
OC - Oceania 16
Totale 5.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.475
RU - Federazione Russa 753
SG - Singapore 226
HK - Hong Kong 225
IT - Italia 222
IE - Irlanda 219
CN - Cina 175
SE - Svezia 160
PL - Polonia 91
IN - India 71
BR - Brasile 68
FI - Finlandia 42
JO - Giordania 41
CH - Svizzera 36
DE - Germania 33
FR - Francia 28
IR - Iran 22
GB - Regno Unito 19
AU - Australia 16
CI - Costa d'Avorio 13
ID - Indonesia 13
CA - Canada 12
NL - Olanda 10
ES - Italia 9
KR - Corea 8
TR - Turchia 8
UA - Ucraina 6
VN - Vietnam 6
BE - Belgio 4
CO - Colombia 4
AR - Argentina 3
BD - Bangladesh 3
AT - Austria 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
KG - Kirghizistan 2
MX - Messico 2
PH - Filippine 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.055
Salva come PNG Salva come JPEG
Città #
Santa Clara 881
Dublin 219
Hong Kong 194
Fairfield 191
Chandler 184
Singapore 149
Ashburn 117
Warsaw 89
Woodbridge 84
Altamura 71
Lawrence 71
Cambridge 69
Seattle 67
Wilmington 66
Houston 57
Florence 50
Mumbai 50
Ann Arbor 47
Beijing 46
Princeton 42
Boston 36
Bern 35
Kent 35
Milan 29
Buffalo 28
New York 22
Dearborn 19
Moscow 19
Turku 19
Munich 17
Paris 16
Shanghai 16
Melbourne 15
Los Angeles 14
Medford 14
Abidjan 13
Hefei 13
Jakarta 13
San Diego 12
Helsinki 10
Boardman 9
Falls Church 9
Guangzhou 9
Barcelona 8
Yubileyny 8
Bengaluru 7
Norwalk 7
Seoul 7
Rome 6
São Paulo 6
Frankfurt am Main 5
Jacksonville 5
Lappeenranta 5
Pune 5
Tehran 5
Andover 4
Brussels 4
Dong Ket 4
Montreal 4
Ottawa 4
West Jordan 4
Amsterdam 3
Belo Horizonte 3
Fuzhou 3
Hillsboro 3
Jinan 3
Kunming 3
Livorno 3
London 3
Toronto 3
Ankara 2
Aversa 2
Bishkek 2
Bogotá 2
Bremen 2
Brescia 2
Cairo 2
Chennai 2
Council Bluffs 2
Curitiba 2
Dhaka 2
Falkenstein 2
Florianópolis 2
Hangzhou 2
Ho Chi Minh City 2
Ilford 2
Istanbul 2
Izmir 2
Kemerovo 2
Kilburn 2
Legnaro 2
Lyon 2
Manila 2
Nanchang 2
Nanjing 2
Palermo 2
Redmond 2
Romola 2
Santa Isabel 2
Shenzhen 2
Totale 3.351
Salva come PNG Salva come JPEG
Nome #
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells 197
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 163
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects 162
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 162
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 142
MSCs seeded on bioengineered scaffolds improve skin wound healing in rats. 139
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 132
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 131
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 124
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 123
Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium. 118
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 114
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 111
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 106
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 105
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 102
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 102
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 102
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 101
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 100
Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. 100
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 99
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 99
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 95
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 94
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 94
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 94
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 92
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis 92
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 91
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 87
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 87
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 87
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor 86
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 83
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 83
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 83
GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) 82
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 81
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 81
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 80
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update 80
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 78
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 78
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 76
DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS 74
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 73
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 64
Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS 58
Panel Session Report: Multiple Sclerosis 53
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis? 49
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocols 43
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT 19
Totale 5.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 0 19
2020/2021250 27 24 8 40 22 16 15 14 23 36 15 10
2021/2022280 3 32 12 24 17 5 8 32 15 6 42 84
2022/2023899 57 197 61 35 60 142 117 61 92 0 35 42
2023/2024472 10 61 50 31 38 57 22 85 9 29 52 28
2024/20252.678 120 290 171 463 698 393 55 126 114 49 98 101
Totale 5.151